Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,267 | -16,413 | -6,671 | -60,663 | -27,152 |
| Depreciation Amortization | 1,634 | 1,050 | 491 | 1,564 | 1,001 |
| Accounts receivable | 1,355 | 1,101 | -1,927 | -1,129 | 275 |
| Accounts payable and accrued liabilities | -909 | -2,086 | 1,027 | 967 | 263 |
| Other Working Capital | 139 | -1,522 | -1,044 | -1,321 | -170 |
| Other Operating Activity | 8,409 | 5,733 | 2,266 | 39,869 | 10,445 |
| Operating Cash Flow | $-16,639 | $-12,137 | $-5,858 | $-20,713 | $-15,338 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,706 | -656 | -307 | -512 | -302 |
| Investing Cash Flow | $-1,706 | $-656 | $-307 | $-512 | $-302 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -332 | -212 | -98 | -201 | -119 |
| Common Stock Issued | 29,143 | 29,143 | 29,143 | 27,814 | 15,825 |
| Other Financing Activity | -487 | -487 | -487 | -7,184 | -6,114 |
| Financing Cash Flow | $28,324 | $28,444 | $28,558 | $20,429 | $9,592 |
| Exchange Rate Effect | -105 | N/A | N/A | N/A | -21 |
| Beginning Cash Position | 10,336 | 10,336 | 10,336 | 11,132 | 11,132 |
| End Cash Position | 20,210 | 25,987 | 32,729 | 10,336 | 5,063 |
| Net Cash Flow | $9,874 | $15,651 | $22,393 | $-796 | $-6,069 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,639 | -12,137 | -5,858 | -20,713 | -15,338 |
| Capital Expenditure | -1,706 | -656 | -307 | -516 | -302 |
| Free Cash Flow | -18,345 | -12,793 | -6,165 | -21,229 | -15,640 |